Pablo Fraile-Ribot

7PUBLICATIONS
38CO-AUTHORS
Medical infection agents (incl. prions)Medical virologyNutritional epidemiologyPharmacogenomicsIntensive care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 16, 2026
In vivo efficacy of cefiderocol against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa carrying the AmpC E219K substitution.

|Apr 10, 2025
[Epidemiological, clinical, and diagnostic analysis of an outbreak of Parvovirus B19 infection in Mallorca Island].

Jordi Reina, Pablo Fraile-Ribot, Julia Viana-Ramírez

|Dec 02, 2024
Q Fever Endocarditis: A Challenging Diagnosis in a Patient Referring Weight Loss and Anorexia, and With Granulomas in Gastric Biopsy Specimens.

Ana Elena Lago-Rodriguez, Pablo Arturo Fraile-Ribot, Isabel Amengual-Antich

|Sep 17, 2024
Impact of transferable β-lactamases and intrinsic AmpC amino acid substitutions on the activity of cefiderocol against wild-type and iron uptake-deficient mutants of Pseudomonas aeruginosa.

Lucía González-Pinto, Tania Blanco-Martín, Isaac Alonso-García

|Jul 29, 2024
Impact of chromosomally encoded resistance mechanisms and transferable β-lactamases on the activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa.

Lucía González-Pinto, Isaac Alonso-García, Tania Blanco-Martín

|Mar 27, 2024
Clinical Characteristics and Microorganisms Isolated in Community-Acquired Pneumonia in the COVID-19 Period.

Meritxell Gavalda, Maria Isabel Fullana, Adrià Ferre

Pageof 2

Frequent Collaborators

3 joint publications

Mercedes García-Gasalla

3 joint publications

Alejandro Beceiro

3 joint publications

Germán Bou

3 joint publications

Juan Carlos Vázquez-Ucha